ES2163028T3 - Composiciones y metodos para detectar y tratar el sindrome de la inmunodeficiencia adquirida. - Google Patents

Composiciones y metodos para detectar y tratar el sindrome de la inmunodeficiencia adquirida.

Info

Publication number
ES2163028T3
ES2163028T3 ES96920118T ES96920118T ES2163028T3 ES 2163028 T3 ES2163028 T3 ES 2163028T3 ES 96920118 T ES96920118 T ES 96920118T ES 96920118 T ES96920118 T ES 96920118T ES 2163028 T3 ES2163028 T3 ES 2163028T3
Authority
ES
Spain
Prior art keywords
compositions
methods
acquired immunodeficiency
immunodeficiency syndrome
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96920118T
Other languages
English (en)
Inventor
Harry P Zhabilov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOMSON USA Ltd
Original Assignee
TOMSON USA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOMSON USA Ltd filed Critical TOMSON USA Ltd
Application granted granted Critical
Publication of ES2163028T3 publication Critical patent/ES2163028T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA INVENCION ESTA RELACIONADA CON EL AREA DE LA INMUNOLOGIA Y LA VIROLOGIA, Y SE REFIERE ESPECIFICAMENTE A COMPOSICIONES OBTENIBLES DE CELULAS DE TIMO DE MAMIFERO QUE SON UTILES COMO AGENTES DIAGNOSTICOS, VACUNALES Y TERAPEUTICOS PARA LA INFECCION POR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA (VIH) Y ENFERMEDADES RELACIONADAS TALES COMO EL SINDROME DE INMUNODEFICIENCIA ADQUIRIDA (SIDA) Y EL COMPLEJO RELACIONADO CON EL SIDA (ARC). SE DESCUBREN ASIMISMO LOS METODOS DE DIAGNOSTICO, VACUNACION Y TERAPEUTICOS, ASI COMO LOS DISPOSITIVOS, QUE EMPLEAN DICHAS COMPOSICIONES.
ES96920118T 1995-05-01 1996-05-01 Composiciones y metodos para detectar y tratar el sindrome de la inmunodeficiencia adquirida. Expired - Lifetime ES2163028T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43188395A 1995-05-01 1995-05-01
US48554895A 1995-06-07 1995-06-07
US64193696A 1996-05-01 1996-05-01

Publications (1)

Publication Number Publication Date
ES2163028T3 true ES2163028T3 (es) 2002-01-16

Family

ID=27411755

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96920118T Expired - Lifetime ES2163028T3 (es) 1995-05-01 1996-05-01 Composiciones y metodos para detectar y tratar el sindrome de la inmunodeficiencia adquirida.

Country Status (11)

Country Link
EP (2) EP0826003B1 (es)
CN (1) CN1221568C (es)
AT (1) ATE205221T1 (es)
BG (1) BG64056B1 (es)
CA (1) CA2220347C (es)
DE (1) DE69615015T2 (es)
DK (1) DK0826003T3 (es)
EA (1) EA001100B1 (es)
ES (1) ES2163028T3 (es)
HK (1) HK1009457A1 (es)
IL (1) IL118103A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008057479A1 (de) 2008-11-14 2010-05-20 Bernhard, Stefan, Dr. Vorrichtung und Verfahren zur Stärkung des Immunsystems durch Langzeitstimulation der Thymusdrüse
CN116466071A (zh) * 2020-12-28 2023-07-21 重庆生命知源科技有限公司 上样缓冲液的应用及一种微量蛋白免疫印迹检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
WO1985003003A1 (en) * 1984-01-12 1985-07-18 Volker Rusch Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes
WO1989005455A1 (en) * 1987-12-02 1989-06-15 The Regents Of The University Of California Aids-related anti-t-cell antibody test
GB9209874D0 (en) * 1992-05-07 1992-06-24 Ml Lab Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
BG102083A (en) 1998-10-30
EA199700353A1 (ru) 1998-04-30
EP0826003A1 (en) 1998-03-04
EP1104770A2 (en) 2001-06-06
DE69615015T2 (de) 2002-06-27
ATE205221T1 (de) 2001-09-15
DE69615015D1 (de) 2001-10-11
DK0826003T3 (da) 2001-11-26
IL118103A (en) 2000-02-29
CA2220347A1 (en) 1996-11-07
IL118103A0 (en) 1997-03-18
CA2220347C (en) 2003-03-18
EP0826003B1 (en) 2001-09-05
CN1221568C (zh) 2005-10-05
EP1104770A3 (en) 2001-06-27
EA001100B1 (ru) 2000-10-30
HK1009457A1 (en) 1999-06-04
CN1189839A (zh) 1998-08-05
BG64056B1 (bg) 2003-11-28

Similar Documents

Publication Publication Date Title
MX9304837A (es) Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico.
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
ZA202107015B (en) Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
ES2174992T3 (es) Productos intermediarios para la obtencion de compuestos inhibidores de proteasas retrovirales.
NO20070137L (no) Heterocykliske antivirale forbindelser
ES2157437T3 (es) Inhibidores de proteasas retrovirales de sulfonilalcanoilamino-hidroxietilamino-sulfonamida.
ECSP034428A (es) Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso
EA200600480A1 (ru) Имидазопиридинзамещённые тропановые производные, обладающие активностью антагониста ccr5 рецептора, для лечения вируса иммунодефицита человека (вич) и воспаления
PA8516701A1 (es) Una composición farmacéutica y procedimiento de tratamiento de enfermedades de disfunción cognitiva en un mamifero
PA8530301A1 (es) Derivados de pirazol para el tratamiento de enfermedades virales
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
UY26920A1 (es) 7 - oxo piridopirimidinas
MX9308005A (es) Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
CL2007000380A1 (es) Compuestos derivados de pirrolo[3,4-c]pirrol sustituidos; antagonista de los receptores ccr5 de quimioquinas ccr5,composicion farmaceutica;y su uso en el tratamiento o prevencion de infecciones por virus de la inmunodeficiencia humana (vih-1)o pra tratar el sida o el arc.
ES2163028T3 (es) Composiciones y metodos para detectar y tratar el sindrome de la inmunodeficiencia adquirida.
ES2061495T3 (es) Peptidos relacionados con el virus htlv-iii, anticuerpos para los peptidos, vacunas, inmunizacion activa y pasiva contra el virus del sida y prueba diagnostica para la deteccion serologica del virus del sida.
AR033702A1 (es) Compuestos triciclicos utiles como inhibidores de la transcriptasa inversa del vih
AR001840A1 (es) Composiciones y métodos para detectar y tratar el sindrome de inmunodeficiencia adquirida
ES2166752T3 (es) Asociacion entre un retrovirus relacionado con el virus de inmunodeficiencia humana y el sindrome de sjogren.
DE60006519D1 (de) Glutathion-reduktase zur behandlung und prophylaxe von aids
ATE247672T1 (de) Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen
ES2081782T3 (es) Extractos procedentes de piliostigma thonningil, su uso y formulaciones que los contienen.
ES2170402T3 (es) Derivados de benzo(g)quinolina.
GT199800165A (es) Polimorfos de dofetilida.
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 826003

Country of ref document: ES